Background: Lethal varicella in immunocompetent hosts is rare and its pathogenesis is largely unknown. The discovery of glycoprotein E (gE) mutants showing attributes consistent with increased virulence in vitro and in animal models, provided a possible molecular mechanism underlying a more aggressive virus infection. However, these mutants have never been associated with unusually severe clinical cases. Objectives: To varicella-zoster virus (VZV) mutations that correlate with increased virulence. Results: We report a case of fatal hepatitis caused by a VZV bearing a novel mutation on the 3B3 monoclonal antibody epitope of gE in an immunocompetent host. Conclusions: This report describes a mutant VZV responsible for an aggressive clinical course in an immunocompetent host. Linking these severe clinical presentations of VZV infection to virus mutations might provide insights into the underlying pathogenic mechanisms.

Natoli, S., Ciotti, M., Paba, P., Testore, G.p., Palmieri, G., Orlandi, A., et al. (2006). A novel mutation of varicella-zoster virus associated to fatal hepatitis. JOURNAL OF CLINICAL VIROLOGY, 37(1), 72-74 [10.1016/j.jcv.2006.06.004].

A novel mutation of varicella-zoster virus associated to fatal hepatitis

NATOLI, SILVIA;TESTORE, GIAN PIERO;PALMIERI, GIAMPIERO;ORLANDI, AUGUSTO;SABATO, ALESSANDRO FABRIZIO;LEONARDIS, FRANCESCA
2006-01-01

Abstract

Background: Lethal varicella in immunocompetent hosts is rare and its pathogenesis is largely unknown. The discovery of glycoprotein E (gE) mutants showing attributes consistent with increased virulence in vitro and in animal models, provided a possible molecular mechanism underlying a more aggressive virus infection. However, these mutants have never been associated with unusually severe clinical cases. Objectives: To varicella-zoster virus (VZV) mutations that correlate with increased virulence. Results: We report a case of fatal hepatitis caused by a VZV bearing a novel mutation on the 3B3 monoclonal antibody epitope of gE in an immunocompetent host. Conclusions: This report describes a mutant VZV responsible for an aggressive clinical course in an immunocompetent host. Linking these severe clinical presentations of VZV infection to virus mutations might provide insights into the underlying pathogenic mechanisms.
2006
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/41 - ANESTESIOLOGIA
English
Con Impact Factor ISI
varicella hepatitis; VZV thymidine kinase mutant virus; severe varicella
CELL SPREAD PHENOTYPE; EVOLUTION; GE
Natoli, S., Ciotti, M., Paba, P., Testore, G.p., Palmieri, G., Orlandi, A., et al. (2006). A novel mutation of varicella-zoster virus associated to fatal hepatitis. JOURNAL OF CLINICAL VIROLOGY, 37(1), 72-74 [10.1016/j.jcv.2006.06.004].
Natoli, S; Ciotti, M; Paba, P; Testore, Gp; Palmieri, G; Orlandi, A; Sabato, Af; Leonardis, F
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
A_novel_mutation_of_varicella-zoster__J_Clin_Virology_2006.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 140.39 kB
Formato Adobe PDF
140.39 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/48140
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 21
social impact